Novel 1,4-benzoxazine and 1,4-benzodioxine inhibitors of angiogenesis

European Journal of Medicinal Chemistry
2012.0

Abstract

Esters of 1,4-benzoxazine and 1,4-benzodioxine compounds 1 and 10, which combine thrombin inhibitory and GPIIb/IIIa antagonistic activity in one molecule are shown to inhibit endothelial cell migration and tube formation in vitro and angiogenesis in the chicken chorioallantoic membrane (CAM) assay. The corresponding carboxylic acids 1 (R(2) = H) and 11 were devoid of anti-angiogenic activity, most probably due to their insufficient entry into the cell. Although thrombin inhibition remains the most probable explanation for their inhibition of angiogenesis, VEGFR2 kinase assay suggest that other targets such as VEGFR2 might be involved.

Knowledge Graph

Similar Paper

Novel 1,4-benzoxazine and 1,4-benzodioxine inhibitors of angiogenesis
European Journal of Medicinal Chemistry 2012.0
Chlorinated benzothiadiazines inhibit angiogenesis through suppression of VEGFR2 phosphorylation
Bioorganic & Medicinal Chemistry 2022.0
Design, synthesis and in vitro evaluation of 6-amide-2-aryl benzoxazole/benzimidazole derivatives against tumor cells by inhibiting VEGFR-2 kinase
European Journal of Medicinal Chemistry 2019.0
Quinoxalinone (Part II). Discovery of (Z)-3-(2-(pyridin-4-yl)vinyl)quinoxalinone derivates as potent VEGFR-2 kinase inhibitors
Bioorganic & Medicinal Chemistry 2016.0
Design, Synthesis, and Biological Evaluation of 3,4-Diarylmaleimides as Angiogenesis Inhibitors
Journal of Medicinal Chemistry 2006.0
Part I. Synthesis, biological evaluation and docking studies of new 2-furylbenzimidazoles as antiangiogenic agents
European Journal of Medicinal Chemistry 2014.0
2,3-Difunctionalized Benzo[b]thiophene Scaffolds Possessing Potent Antiangiogenic Properties
Journal of Medicinal Chemistry 2022.0
Discovery of novel anti-angiogenesis agents. Part 10: Multi-target inhibitors of VEGFR-2, Tie-2 and EphB4 incorporated with 1,2,3-triazol
European Journal of Medicinal Chemistry 2019.0
Discovery of arylamide-5-anilinoquinazoline-8-nitro derivatives as VEGFR-2 kinase inhibitors: Synthesis, in vitro biological evaluation and molecular docking
Bioorganic & Medicinal Chemistry Letters 2019.0
Synthesis, in vitro and in vivo preliminary evaluation of anti-angiogenic properties of some pyrroloazaflavones
Bioorganic & Medicinal Chemistry 2011.0